171 related articles for article (PubMed ID: 10518844)
1. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid.
Szefler SJ
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):175-83. PubMed ID: 10518844
[TBL] [Abstract][Full Text] [Related]
2. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
3. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma.
Szefler SJ; Eigen H
J Allergy Clin Immunol; 2002 Apr; 109(4):730-42. PubMed ID: 11941331
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of nebulized budesonide inhalation suspension in a child with asthma.
Skoner DP; Angelini BL; Friday G; Gentile D
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):210-4. PubMed ID: 10518848
[TBL] [Abstract][Full Text] [Related]
5. A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.
Kantar A; Mroueh S; Fiocchi A
Allergy Asthma Proc; 2007; 28(6):671-87. PubMed ID: 17883883
[TBL] [Abstract][Full Text] [Related]
6. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
Leflein JG; Szefler SJ; Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Smith JA
Pediatrics; 2002 May; 109(5):866-72. PubMed ID: 11986448
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
McLaughlin T; Leibman C; Patel P; Camargo CA
Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
[TBL] [Abstract][Full Text] [Related]
8. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
Dahlström K; Thorsson L; Larsson P; Nikander K
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671
[TBL] [Abstract][Full Text] [Related]
9. Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.
Boobis AR
Respir Med; 1998 Jul; 92 Suppl B():2-6. PubMed ID: 10193529
[TBL] [Abstract][Full Text] [Related]
10. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children.
Agertoft L; Andersen A; Weibull E; Pedersen S
Arch Dis Child; 1999 Mar; 80(3):241-7. PubMed ID: 10325704
[TBL] [Abstract][Full Text] [Related]
11. Impact of constant and breath-synchronized nebulization on inhaled mass of nebulized budesonide in infants and children.
Nikander K; Bisgaard H
Pediatr Pulmonol; 1999 Sep; 28(3):187-93. PubMed ID: 10495335
[TBL] [Abstract][Full Text] [Related]
12. Meeting needs of infants and young children with asthma: new developments in nebulized corticosteroid therapy. Introduction.
Szefler SJ
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):159-61. PubMed ID: 10518841
[No Abstract] [Full Text] [Related]
13. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
Kemp JP; Skoner DP; Szefler SJ; Walton-Bowen K; Cruz-Rivera M; Smith JA
Ann Allergy Asthma Immunol; 1999 Sep; 83(3):231-9. PubMed ID: 10507269
[TBL] [Abstract][Full Text] [Related]
14. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma.
Mellon M; Leflein J; Walton-Bowen K; Cruz-Rivera M; Fitzpatrick S; Smith JA
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):593-8. PubMed ID: 10934092
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
Nicolini G; Cremonesi G; Melani AS
Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
[TBL] [Abstract][Full Text] [Related]
16. Review of the unique properties of budesonide.
O'Connell EJ
Clin Ther; 2003; 25 Suppl C():C42-60. PubMed ID: 14642803
[TBL] [Abstract][Full Text] [Related]
17. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
Scott MB; Skoner DP
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
Mellon M
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
White MV; Cruz-Rivera M; Walton-Bowen K
Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
